ANAPTYSBIO, INC - 8-K Filing
AnaptysBio appointed Christopher M. Murphy as Chief Financial Officer effective May 11, 2026, with a monthly consulting fee of $42,916.66, an annual target cash bonus opportunity up to 40% of total fees, and an equity grant worth $1.75 million vesting over four years. The company also appointed Owen Hughes as a Class I director on the same date, who received an initial restricted stock unit grant of 11,250 shares. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $ANAB